11.33
price up icon6.59%   0.70
after-market Handel nachbörslich: 11.34 0.010 +0.09%
loading
Schlusskurs vom Vortag:
$10.63
Offen:
$10.45
24-Stunden-Volumen:
7,931
Relative Volume:
0.29
Marktkapitalisierung:
$54.80M
Einnahmen:
$2.61M
Nettoeinkommen (Verlust:
$1.69M
KGV:
37.73
EPS:
0.3003
Netto-Cashflow:
-
1W Leistung:
+0.44%
1M Leistung:
+17.29%
6M Leistung:
+50.27%
1J Leistung:
+23.56%
1-Tages-Spanne:
Value
$10.27
$11.33
1-Wochen-Bereich:
Value
$10.00
$11.35
52-Wochen-Spanne:
Value
$6.55
$11.38

Daxor Corporation Stock (DXR) Company Profile

Name
Firmenname
Daxor Corporation
Name
Telefon
212-330-8500
Name
Adresse
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Name
Mitarbeiter
0
Name
Twitter
@DaxorBVA
Name
Nächster Verdiensttermin
2025-03-05
Name
Neueste SEC-Einreichungen
Name
DXR's Discussions on Twitter

Vergleichen Sie DXR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
DXR
Daxor Corporation
11.33 51.71M 2.61M 1.69M 0 0.3003
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
454.52 168.15B 9.15B 2.63B 1.99B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
191.26 53.93B 21.39B 1.61B 2.55B 5.56
Medical Instruments & Supplies icon
RMD
Resmed Inc
273.81 39.68B 5.15B 1.40B 1.65B 9.51
Medical Instruments & Supplies icon
ALC
Alcon Inc
78.91 38.70B 10.03B 1.07B 1.39B 2.17
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
247.54 17.53B 2.96B 487.70M 344.00M 6.68

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2019-05-16 Eingeleitet Ascendiant Capital Markets Buy

Daxor Corporation Aktie (DXR) Neueste Nachrichten

pulisher
Sep 03, 2025

Can Daxor Corporation deliver consistent EPS growthQuarterly Performance Summary & High Accuracy Investment Entry Signals - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Understanding Daxor Corporation’s price movementJuly 2025 PreEarnings & Real-Time Price Movement Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Daxor Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire

Sep 03, 2025
pulisher
Sep 03, 2025

Blood Volume Tech Leader Daxor Corporation to Present at Major Global Investment Conference in NYC - Stock Titan

Sep 03, 2025
pulisher
Sep 03, 2025

Daxor Corporation stock retracement – recovery analysisTrade Risk Report & Reliable Entry Point Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Does Daxor Corporation qualify in momentum factor screeningMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Applying Elliott Wave Theory to Daxor Corporation2025 Trade Ideas & Safe Entry Momentum Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What momentum shifts mean for Daxor CorporationJuly 2025 Highlights & Real-Time Volume Analysis - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Analyzing Daxor Corporation with risk reward ratio chartsJuly 2025 Macro Moves & Real-Time Buy Zone Alerts - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Can Daxor Corporation withstand a market correctionWeekly Trend Recap & Expert Curated Trade Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Will Daxor Corporation benefit from AI trendsJuly 2025 Movers & Safe Entry Momentum Stock Tips - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Daxor reports increase in NAV to $7.15 per share - TipRanks

Sep 02, 2025
pulisher
Sep 02, 2025

Has Daxor Corporation formed a bullish divergenceQuarterly Portfolio Report & AI Powered Market Entry Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter - The Manila Times

Sep 02, 2025
pulisher
Sep 02, 2025

Daxor Corp reports mid-year update, significant progress in blood volume measurement technology. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 07:04:39 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

3X Faster Blood Analysis: Daxor's New FDA-Cleared Device Drives 73% Revenue Jump in Game-Changing H1 - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

What candlestick patterns are forming on Daxor Corporation2025 Risk Factors & AI Based Buy and Sell Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How to forecast Daxor Corporation trends using time seriesQuarterly Profit Report & Expert Approved Momentum Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Does Daxor Corporation fit your quant trading modelWeekly Risk Report & AI Powered Trade Plan Recommendations - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Live market analysis of Daxor CorporationQuarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Is Daxor Corporation in a long term uptrendQuarterly Profit Review & Community Consensus Trade Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Combining machine learning predictions for Daxor CorporationJuly 2025 Gainers & Safe Entry Trade Signal Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Chart based analysis of Daxor Corporation trends2025 Market Outlook & Expert Curated Trade Setups - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Using data models to predict Daxor Corporation stock movementQuarterly Portfolio Review & High Accuracy Swing Trade Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Published on: 2025-09-01 11:16:03 - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is it time to cut losses on Daxor Corporation2025 Biggest Moves & Daily Stock Trend Watchlist - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Analyzing drawdowns of Daxor Corporation with statistical tools2025 Price Action Summary & Weekly Consistent Profit Watchlists - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

AI Tools Suggest Daxor Corporation May Outperform This Week getLinesFromResByArray error: size == 0 - kangso.co.kr

Aug 31, 2025
pulisher
Aug 31, 2025

Using economic indicators to assess Daxor Corporation potentialJuly 2025 PreEarnings & Consistent Profit Trading Strategies - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Daxor Corporation stock chart pattern explainedWeekly Investment Summary & AI Forecasted Entry and Exit Points - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Applying sector rotation models to Daxor CorporationRisk Management & Reliable Entry Point Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

What the charts say about Daxor Corporation today2025 Fundamental Recap & High Accuracy Investment Signals - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Short Interest Drops in Daxor Corporation After Rally getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 30, 2025

Finanzdaten der Daxor Corporation-Aktie (DXR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$134.70
price up icon 1.77%
medical_instruments_supplies BAX
$23.58
price up icon 0.17%
$72.38
price up icon 1.37%
medical_instruments_supplies COO
$68.00
price up icon 1.28%
$66.39
price up icon 0.23%
medical_instruments_supplies WST
$247.54
price down icon 0.57%
Kapitalisierung:     |  Volumen (24h):